The heterogeneity of Castleman disease: Report of five cases and review of the literature

American Journal of the Medical Sciences

Volumn 320, Issue 4, 2000, Pages 292-295

  Maslovsky, Igor ^a   Uriev, Leonid ^a   Lugassy, Gilles ^a  

^a BARZILAI MEDICAL CENTER   (Israel)

Author keywords

Castleman disease

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; MELPHALAN; PREDNISONE; VINCRISTINE;

AGED; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; MALE; TREATMENT OUTCOME;

EID: 0033792454     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9629(15)40843-2     Document Type: Article

References (28)

1. Localized mediastinal lymph-node hyperplasia resembling thymoma
2. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations
3. The clinical behavior of localized and multicentric Castleman disease
4. Clonal rearrangement for immunoglobulin and T-cell receptor genes in systemic Castleman's disease. Association with Epstein-Barr virus
5. Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody
6. Interleukin-6 gene expression in Castleman's disease
7. Expression of interleukin-6 in Castleman's disease
8. Interleukin-6 production in B-cell neoplasias and Castleman's disease: Evidence for an additional paracrine loop
9. Interleukin-6 receptor expression in the peripheral B cells of patients with multicentric Castleman's disease
10. Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells
11. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease
12. Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus
13. Kaposi's sarcoma-associated herpesvirus: A lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
14. Human herpesvirus type-8 (HHV-8) in haematopoietic neoplasia
15. Detection of human herpesvirus 8 in patients with Kaposi's sarcoma or Castleman's disease associated with AIDS
16. Elevated levels of tumor necrosis factor-beta, gamma-interferon, and IL-6 mRNA in Castleman's disease
17. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease
18. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease
19. Multicentric Castleman's disease with an increased serum level of macrophage colony-stimulating factor
20. Apoptosis of T cells in multicentric Castleman's disease
21. A successfully treated case of multicentric angiofollicular hyperplasia with oral chemotherapy (Castleman's disease)
22. Autoimmune hemolytic anemia in multicentric Castleman's disease
23. Treatment of an abdominal form of Castleman's disease by chemotherapy
24. Aggressive angiofollicular lymph node hyperplasia (Castleman's disease) treated with high dose melphalan and autologous bone marrow transplantation
25. A plasma cell variant of Castleman's disease treated successfully with cimetidine. Case report and review of the literature
26. The management of unicentric and multicentric Castleman's disease: A report of 16 cases and a review of the literature
27. Erythropoietin improved anemia in a case of multicentric Castleman's disease
28. A case of multicentric Castleman's disease associated with renal amyloidosis and pure red cell aplasia